Home > Healthcare > Medical Devices > Infection Control > Ionizing Radiation Sterilization Equipment Market

Ionizing Radiation Sterilization Equipment Market Trends

Report ID: GMI6127
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Ionizing Radiation Sterilization Equipment Market Trends

Growing awareness regarding the importance of infection control and prevention measures and an increasing number of hospitals acquired infections (HAIs) in healthcare settings are a few major factors contributing to the market revenue. As per estimates from the World Health Organization (WHO), out of every 100 patients admitted under acute care in hospitals, 15 patients in low- and middle-income countries and 7 patients in high-income countries will be infected by any one of the hospital-acquired infections during their hospital stay. Nosocomial infections affect a substantial number of patients globally making it one of the leading causes of mortality among patients.

According to the World Health Organization (WHO) data, approximately 1 in every 10 patients infected with hospital-acquired infections die due to the condition. Thus, an increasing number of hospital-acquired will propel the market share. Also, a high focus on patient safety and minimization of HAIs will drive the demand for effective ionizing radiation sterilization equipment. Further, the surge in the adoption of advanced sterilization technologies to enhance infection control practices and mitigate the risk of HAIs among healthcare facilities will fortify industry revenue growth.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

The market size of ionizing radiation sterilization equipment was reached USD 4 billion in 2022 and will account for USD 12.2 billion by 2032, owing to rising demand for healthcare products and increasing awareness of sterilization practices.

The viral inactivation segment accounted for over 47% market share in the year 2022, attributable to the increasing demand for biopharmaceuticals, advancements in analytical techniques, and emerging viral threats.

U.S. market accounted for USD 1.6 billion in 2022, backed by the increasing geriatric population base that are highly prone to several infectious diseases.

Getinge AB, STERIS, Sotera Health, Bioster a.s., Röchling SE & Co. KG, Symec Engineers (India) Pvt. Ltd., BGS Beta-Gamma-Service GmbH & Co. KG, IBA Worldwide, E-BEAM Services, Inc., Belimed AG, Atec Pharmatechnik GmbH, Noxilizer, Inc. and Tuttaner.